Klf15-flox Mouse
一般名
Klf15-flox
製品ID
S-CKO-12989
背景情報
C57BL/6JCya
系統ID
CKOCMP-66277-Klf15-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Klf15-flox Mouse(カタログ番号S-CKO-12989)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Klf15-flox
系統ID
CKOCMP-66277-Klf15-B6J-VA
遺伝子名
製品ID
S-CKO-12989
遺伝子別名
CKLF, KKLF, hlb444, 1810013I09Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000032174
NCBIトランスクリプトID
NM_023184
ターゲット領域
Exon 2
有効領域の大きさ
~2.0 kb
遺伝子研究の概要
Klf15, also known as Krüppel-like factor 15, is a transcription factor with diverse biological functions. It is involved in multiple pathways, such as those related to metabolism, inflammation, and cell-phenotype regulation, playing an overall crucial role in maintaining normal physiological functions and in disease-related processes. Genetic models, like gene knockout (KO) and conditional knockout (CKO) mouse models, are valuable tools for studying Klf15's functions.
In immobility-induced muscle atrophy, mice with skeletal muscle KLF15 deficiency are protected from atrophy, suggesting Klf15 is part of the Piezo1/KLF15/IL-6 axis mediating this atrophy [1]. In cardiac ischemic injury, WWP1 targets KLF15 for polyubiquitination and degradation, exacerbating cardiomyocyte inflammation; inhibition of WWP1 mitigates this [2]. In pancreatic cancer, KLF15 suppresses cancer stem cell stemness by promoting Nanog degradation [3]. In hypertensive renal injury, SIRT7 mitigates renal ferroptosis, fibrosis, and injury by facilitating the KLF15/Nrf2 signaling [4]. In the heart, KLF15 is an inhibitor of pathological cardiac hypertrophy and fibrosis [5]. In liver, KLF15-Cyp3a11 axis regulates rifampicin-induced liver injury; KLF15 knockout attenuates hepatotoxicity of rifampicin [6]. In thoracic aortic dissection, Klf15KO mice are more susceptible to TAD, and KLF15 maintains VSMC contractile phenotype by interacting with MRTFB [7]. In cardiomyocytes, KLF15 deficiency leads to increased oxidative stress due to reduced NAMPT and NAD + levels [8]. In triple-negative breast cancer, exogenous KLF15 suppresses cell growth and metastasis by downregulating CCL2 and CCL7 [9].
In conclusion, Klf15 is involved in a wide range of biological processes including muscle atrophy, cardiac function, cancer stemness, renal injury, and more. The use of Klf15 KO/CKO mouse models has significantly contributed to understanding its role in diseases such as muscle atrophy, cardiac ischemic injury, pancreatic cancer, hypertensive renal injury, and others, providing potential therapeutic targets for these conditions.
References:
1. Hirata, Yu, Nomura, Kazuhiro, Kato, Daisuke, Wake, Hiroaki, Ogawa, Wataru. 2022. A Piezo1/KLF15/IL-6 axis mediates immobilization-induced muscle atrophy. In The Journal of clinical investigation, 132, 1-13. doi:10.1172/JCI154611. https://pubmed.ncbi.nlm.nih.gov/35290243/
2. Lu, Xia, Yang, Boshen, Qi, Ruiqiang, Wang, Yan, Song, Juan. 2023. Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation. In Theranostics, 13, 417-437. doi:10.7150/thno.77694. https://pubmed.ncbi.nlm.nih.gov/36593958/
3. Jiang, Wenna, Liu, Lin, Wang, Meng, Liu, Jing, Ren, Li. 2024. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. In Cellular and molecular life sciences : CMLS, 81, 417. doi:10.1007/s00018-024-05442-6. https://pubmed.ncbi.nlm.nih.gov/39367978/
4. Li, Xue-Ting, Song, Jia-Wei, Zhang, Zhen-Zhou, Liu, Xiao-Yan, Zhong, Jiu-Chang. 2022. Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15/Nrf2 signaling. In Free radical biology & medicine, 193, 459-473. doi:10.1016/j.freeradbiomed.2022.10.320. https://pubmed.ncbi.nlm.nih.gov/36334846/
5. Zhao, Yuguang, Song, Wenjing, Wang, Lizhe, Han, Fujun, Cai, Lu. 2019. Multiple roles of KLF15 in the heart: Underlying mechanisms and therapeutic implications. In Journal of molecular and cellular cardiology, 129, 193-196. doi:10.1016/j.yjmcc.2019.01.024. https://pubmed.ncbi.nlm.nih.gov/30831134/
6. Hou, Wanqing, Huo, Ku-Geng, Guo, Xiaohua, Ma, Zhenghai, Han, Shuxin. 2024. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury. In Drug metabolism and disposition: the biological fate of chemicals, 52, 606-613. doi:10.1124/dmd.123.001617. https://pubmed.ncbi.nlm.nih.gov/38670799/
7. Fang, Guangming, Tian, Yexuan, Huang, Shan, Du, Jie, Gao, Shijuan. 2024. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB. In The Journal of biological chemistry, 300, 107260. doi:10.1016/j.jbc.2024.107260. https://pubmed.ncbi.nlm.nih.gov/38582447/
8. Li, Le, Xu, Weiyi, Zhang, Lilei. 2021. KLF15 Regulates Oxidative Stress Response in Cardiomyocytes through NAD. In Metabolites, 11, . doi:10.3390/metabo11090620. https://pubmed.ncbi.nlm.nih.gov/34564436/
9. Kanyomse, Quist, Le, Xin, Tang, Jun, Zeng, Xiaohua, Xiang, Tingxiu. 2022. KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7. In Scientific reports, 12, 19026. doi:10.1038/s41598-022-23750-4. https://pubmed.ncbi.nlm.nih.gov/36347994/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
